Career & Filing History
Every role Mary T. Szela has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
Mary T. Szela serves as Director of Absci Corp (ABSI). Szela has also held reporting roles at TriSalus Life Sciences, Inc. (TLSI) and Kura Oncology, Inc. (KURA). Szela has reported 10 insider filings with the SEC since 2025. The most recent filing was in July 2026.
Every role Mary T. Szela has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
Absci Corp (ABSI)3 filingsTriSalus Life Sciences, Inc. (TLSI)1 filingKura Oncology, Inc. (KURA)1 filingUpdated Aug 30, 2026
Mary T. Szela is Director of Absci Corp (ABSI). 10 SEC Form 4 filings on record going back to 2025, most recently on 6 July 2026. Most recent open-market trade: bought $149K of ABSI on 6 July 2026. Lifetime open-market purchases: $377K. Lifetime open-market sales: $79K.
Every recent SEC Form 4 transaction Mary T. Szela has reported, most recent first.
InsiderAlpha's records for Mary T. Szela go back to 2025: 10 primary Form 4 filings, an average of 5.0 per year. The typical open-market purchase is $126K (3 buys totaling $377K). The largest single buy on record is $149K of ABSI in 2026. Sales side: 2 recorded sales totaling $79K, so the filing history runs buy-heavy by dollar value. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Insiders who reported open-market trades in the last 12 months at the companies Mary T. Szela files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Mary T. Szela is a corporate insider, tracked as Director of Absci Corp (ABSI). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
5 primary Form 4 filings in the last 90 days, covering 3 companies.
Recorded transactions: 3 open-market purchases ($377K) and 2 open-market sales ($79K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
$ABSI Absci Corp8.4K shares @ $0.00-